DVYSR — Devyser Diagnostics AB Share News
0.000.00%
Last trade - 00:00- SEK1.42bn
- SEK1.39bn
- SEK250.50m
Brief: Devyser Diagnostics Is Not Proposing Dividend For 2024
Brief: CEO Leaves Devyser
Brief: Devyser Preliminary Q4 EBIT Turns To Profit Of SEK 0.7 Mln
Brief: Devyser Achieves Class D Ivdr Approval For RHD Product
Brief: Devyser Says Is Confident In Reaching Financial Targets
Brief: Devyser Q3 Sales SEK 48.7 Million
Brief: Devyser Seeks To Secure FDA Approval
Brief: Devyser Compact Achieves Class III Approval In China
Brief: Devyser Q2 Sales SEK 53.2 Million
Brief: Devyser Wins Tender In Italy
Brief: Devyser Wins Tender Worth Up To SEK 8.4 Million
Brief: Devyser Expands Commercial Agreement With Thermo Fisher Scientific
Brief: Devyser Diagnostics Gets Tender For Up To SEK 75 Mln
Brief: Devyser Wins Tender Of Up To SEK 5.5 Mln For Oncology NGS Solutions In Italy
Brief: Devyser Wins Tender Of About SEK 3.5 Mln For Thalassemia In Italy
Brief: Devyser Q1 Sales SEK 50.7 Million
Brief: Devyser Gets IVDR Approval For Post-Transplant Monitoring Software
Brief: Devyser Diagnostics Partners With Hamilton
Brief: Devyser Gets MDSAP Certification For Brazil